Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma

Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma is a topic covered in the Evidence-Based Medicine Guidelines.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma ID - 452753 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/452753/all/Chemotherapy_plus_Rituximab_versus_chemotherapy_alone_for_B_cell_non_Hodgkin's_lymphoma PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -